One-year clinical outcomes of transcatheter aortic valve implantation with the latest iteration of self-expanding or balloonexpandable devices: insights from the OPERA-TAVI registry.

Giuliano Costa,Francesco Saia,Thomas Pilgrim,Mohamed Abdel-Wahab,Philippe Garot, Sofia Sammartino,Caterina Gandolfo,Luca Branca,Azeem Latib,Ignacio Amat-Santos,Darren Mylotte,Federico De Marco,Ole De Backer,Luis Nombela Franco,Mariama Akodad,Flavio Luciano Ribichini,Francesco Bedogni, Alessandro Mazzapicchi,Daijiro Tomii,Pietro Laforgia,Stefano Cannata,Claudia Fiorina,Andrea Scotti,Simone Fezzi,Enrico Criscione,Enrico Poletti,Mattia Mazzucca,Mattia Lunardi,Andrea Mainardi, Stefano Andreaggi,Angelo Quagliana,Nicholas Montarello,Breda Hennessey,Matias Mon-Noboa,David Meier,Marianna Adamo,Carmelo Sgroi,Claudia Maria Reddavid,Orazio Strazzieri,Silvia Crescenzia Motta,Valentina Frittitta,Elena Dipietro,Alessandro Comis, Chiara Melfa,Mariachiara Calì,Giulia Laterra,Holger Thiele,John G Webb,Lars Sondergaard,Corrado Tamburino,Marco Barbanti

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology（2023）

引用 0|浏览35

暂无评分

摘要

One-year clinical outcomes of patients undergoing transfemoral TAVI and receiving PRO or ULTRA devices in the current clinical practice were similar, but PRO patients had higher rates of disabling stroke. Outcomes did not differ across the different anatomical subsets of the aortic root.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要